View Document Preview and Link Open Document File Size: 2,15 MB Share Result on Facebook
City Shanghai / / Company Boorjian SA / Cox / adjuvant RT. / IBM Corp. / Eastern Cooperative Oncology Group / / Country Taiwan / United States / China / / Currency VND / / / Facility Shanghai Medical College / Fudan University / / IndustryTerm therapy for node-positive prostate cancer / / MedicalCondition lymph node metastases / pelvic lymphadenopathy / cancers / Tumor / advanced prostate cancer / common cancer / cancer / JE / disease / nodal metastases / prostatectomy Background Prostate cancer / metastasis / positive prostate cancer / lethal male urogenital system cancer / malignant disease / few lymph node metastases / J Cancer / metastatic disease / systemic disease / progressive prostate cancer / node-positive disease Risk factor HR / lymph nodes metastases / low-volume nodal metastases / intraprostatic cancer / node-positive prostate cancer / LNM disease / prostate cancer / advanced diseases / metastatic hormone-sensitive prostate cancer / lymph node metastasis / distant metastases / newly disseminated cancer / nondiploid tumor / primary tumor / / MedicalTreatment prostatectomy / hormone therapy / adjuvant therapies / surgery / radiation / adjuvant therapy / / Organization Fudan University / Shanghai / Department of Oncology / Shanghai Medical College / American Society of Clinical Oncology / Fudan University Shanghai Cancer Center / Department of Urology / / Person Yiping Zhu / / Position physician / Corresponding author / / Product testosterone / / Technology radiation / gene expression / HTML / PDF / / URL http / SocialTag 
World Journal of Surgical Oncology This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Outcomes of patients with